Off-patent Drugs Bill (HC Bill 22)
Contents
-
Part 1
Licensing of existing off-patent drugs
-
1. Duty of the Secretary of State to take steps to secure a licence for off-patent
drugs in new indications -
2. Exercise of Secretary of State’s duty to take steps to secure a licence for off-
patent drugs in new indications -
3. Regulations as to the exercise by the Secretary of State of the duty to take steps
to secure licences for off-patent drugs
-
-
Part 2
Provisions relating to conducting NICE technology appraisals for off-patent
drugs -
Part 3
General provisions